Showing results (531-540 of 4,042) with videos related to
Sort By:
Pageof 405
Pharmacoepidemiology and Drug Safety|December 13, 2019
Understanding utilization patterns of biologics and biosimilars in the United States to support postmarketing studies of safety and effectivenessSarah K Dutcher, Elnara Fazio-Eynullayeva, Efe Eworuke, et al.Pharmacoepidemiology and Drug Safety|January 21, 2020
Comparison of medication adherence measures derived from linked administrative data and associations with mortality using restricted cubic splines in heart failure patientsXiwen Qin, Joseph Hung, Matthew W Knuiman, et al.Pharmacoepidemiology and Drug Safety|December 19, 2019
Long-term opioid therapy definitions and predictors: A systematic reviewRuchir N Karmali, Christopher Bush, Sudha R Raman, et al.Pharmacoepidemiology and Drug Safety|May 27, 2022
Core concepts in pharmacoepidemiology: Fundamentals of the cohort and case-control study designsAnton PottegårdPharmacoepidemiology and Drug Safety|January 24, 2018
Trends and uptake of new formulations of controlled-release oxycodone in CanadaTara Gomes, Sonia Jain, J Michael Paterson, et al.Pharmacoepidemiology and Drug Safety|February 1, 2018
Addressing unmeasured confounding in comparative observational researchXiang Zhang, Douglas E Faries, Hu Li, et al.Pharmacoepidemiology and Drug Safety|February 3, 2018
Do FDA label changes work? Assessment of the 2010 class label change for proton pump inhibitors using the Sentinel System's analytic toolsRachel E Sobel, Andrew Bate, James Marshall, et al.Pharmacoepidemiology and Drug Safety|January 10, 2018
Treatment dynamics of bone-targeting agents among men with bone metastases from prostate cancer in the United StatesAnne M Butler, Karynsa Cetin, Rohini K Hernandez, et al.Pharmacoepidemiology and Drug Safety|December 15, 2018
Validation study of colorectal cancer diagnosis in the Spanish primary care database, BIFAPMiguel Gil, Antonio Rodríguez-Miguel, Héctor Montoya-Catalá, et al.Pharmacoepidemiology and Drug Safety|June 10, 2022
Ileus in patients treated with immune checkpoint inhibitors: A retrospective, pharmacovigilance study using Food and Drug Administration Adverse Event Reporting System databaseSiyuan Gao, Zhichao He, Jianhong Zhu, et al.Pageof 405